CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,466,459
- in 2 filings
Net −$1,466,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-22 | Davis George Eric EVP, General Counsel | Shares withheld for taxes | −1,391 | $78.52 | $109K | 68,440 |
| 2021-03-22 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −5,519 | $78.52 | $433K | 302,498 |
| 2021-03-22 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −1,513 | $78.52 | $119K | 62,620 |
| 2021-03-18 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Sale | −1,308 | $77.99 | $102K | 64,133 |
| 2021-03-16 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −582 | $77.21 | $45K | 37,224 |
| 2021-03-16 | Davis George Eric EVP, General Counsel | Shares withheld for taxes | −1,252 | $77.21 | $97K | 69,831 |
| 2021-03-16 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −2,259 | $77.21 | $174K | 108,596 |
| 2021-03-16 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Shares withheld for taxes | −1,287 | $77.21 | $99K | 65,441 |
| 2021-03-16 | BIENAIME JEAN JACQUES Chief Executive Officer | Shares withheld for taxes | −5,559 | $77.21 | $429K | 308,017 |
| 2021-03-16 | Acosta Andrea GVP, Chief Accounting Officer | Shares withheld for taxes | −379 | $77.21 | $29K | 18,136 |
| 2021-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +10,420 | 45,460 | ||
| 2021-03-15 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award · Stock Option (Right to buy Common Stock) | +25,650 | 25,650 | ||
| 2021-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +10,110 | 38,800 | ||
| 2021-03-15 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −994 | $78.39 | $78K | 37,806 |
| 2021-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +24,890 | 24,890 | ||
| 2021-03-15 | Davis George Eric EVP, General Counsel | Grant or award | +10,420 | 76,097 | ||
| 2021-03-15 | Davis George Eric EVP, General Counsel | Shares withheld for taxes | −5,014 | $78.39 | $393K | 71,083 |
| 2021-03-15 | Davis George Eric EVP, General Counsel | Grant or award · Stock Option (Right to buy Common Stock) | +25,650 | 25,650 | ||
| 2021-03-15 | FUCHS HENRY J President, Worldwide R&D | Grant or award | +15,320 | 118,315 | ||
| 2021-03-15 | FUCHS HENRY J President, Worldwide R&D | Shares withheld for taxes | −7,460 | $78.39 | $585K | 110,855 |
Page 31 of 36 · 707 trades